In the news
The Top Healthcare Technology Companies of 2026: Volume I
July 1, 2026 /In the News/ -- The Healthcare Technology Report named Digbi Health to the first volume of its Top Healthcare Technology Companies of 2026, listing it in the Digital Health category. The editors built the list around companies that remove specific points of friction in care delivery rather than around size or brand recognition, and placed Digbi among awardees working in diagnostics, AI software and medical technology.
The feature centers on a problem employers know well: members with overlapping chronic conditions, such as obesity, diabetes, digestive and inflammatory disorders, who are usually enrolled in a separate program for each. Digbi reads each member's genetics, gut microbiome, glucose response and blood biomarkers, then uses AI and clinician-guided care to turn that profile into a single plan spanning food, medication and coaching. The publication also highlights GLP Compass, Digbi's GLP-1 program, which uses biological data to anticipate how a member will respond to the drugs, which side effects to expect, and when tapering may be appropriate.
For employers and health plans, the recognition adds independent weight to the case for consolidating point solutions into one biology-led platform, at a moment when GLP-1 spending is forcing benefits leaders to ask which members will actually benefit from the medication.
Read the original announcement
About Digbi Health
Digbi Health is the precision biology care company unifying metabolic and inflammatory care — including obesity, cardiometabolic, gastrointestinal, and inflammatory disorders. These illnesses share a root cause: a mismatch between an individual's biology and the one-size-fits-all lifestyle guidance they've been given. Digbi combines the gut microbiome, genetics, advanced blood biomarkers, and continuous digital health data to build a unique biological profile for each individual and identify what is driving their disease. AI then personalizes lifestyle treatment and, when needed, clinical treatment, delivered through the first precision-biology AI-orchestrated national telehealth platform. Through Digbi Labs, we invest in our vision of making chronic illness optional and advancing healthspan — partnering with leading universities, pharmaceutical companies, and scientific and clinical laboratories, running distributed human trials and publishing peer-reviewed research on genetics, the gut microbiome, and the use of AI to deliver care that is safe, cost-effective, and accessible. Digbi's healthcare cost reduction is documented in multiple peer-reviewed actuarial claims studies. Digbi is accessible to 30 million individuals through more than 300 employers and health plans.
SOURCE The Healthcare Technology Report